BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26679037)

  • 1. Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms.
    Wong Doo N; Makalic E; Joo JE; Vajdic CM; Schmidt DF; Wong EM; Jung CH; Severi G; Park DJ; Chung J; Baglietto L; Prince HM; Seymour JF; Tam C; Hopper JL; English DR; Milne RL; Harrison SJ; Southey MC; Giles GG
    Epigenomics; 2016 Jan; 8(1):55-66. PubMed ID: 26679037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
    Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that general genomic hypomethylation and focal hypermethylation are two independent molecular events of non-Hodgkin's lymphoma.
    Pini JT; Franchina M; Taylor JM; Kay PH
    Oncol Res; 2004; 14(7-8):399-405. PubMed ID: 15301431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
    Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
    Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
    Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
    Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.
    Dugué PA; Brinkman MT; Milne RL; Wong EM; FitzGerald LM; Bassett JK; Joo JE; Jung CH; Makalic E; Schmidt DF; Park DJ; Chung J; Ta AD; Bolton DM; Lonie A; Longano A; Hopper JL; Severi G; Saffery R; English DR; Southey MC; Giles GG
    Br J Cancer; 2016 Sep; 115(6):664-73. PubMed ID: 27490804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil.
    Borges Bdo N; Santos Eda S; Bastos CE; Pinto LC; Anselmo NP; Quaresma JA; Calcagno DQ; Burbano RM; Harada ML
    Anticancer Res; 2010 Jun; 30(6):2225-33. PubMed ID: 20651373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.
    Kordi-Tamandani DM; Moazeni-Roodi AK; Rigi-Ladiz MA; Hashemi M; Birjandian E; Torkamanzehi A
    Arch Oral Biol; 2010 Oct; 55(10):809-14. PubMed ID: 20674887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma.
    Lee EJ; Lee BB; Han J; Cho EY; Shim YM; Park J; Kim DH
    Int J Cancer; 2008 Nov; 123(9):2073-9. PubMed ID: 18697202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
    Eads CA; Lord RV; Kurumboor SK; Wickramasinghe K; Skinner ML; Long TI; Peters JH; DeMeester TR; Danenberg KD; Danenberg PV; Laird PW; Skinner KA
    Cancer Res; 2000 Sep; 60(18):5021-6. PubMed ID: 11016622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
    Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
    Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant DNA methylation patterns of spermatozoa in men with unexplained infertility.
    Urdinguio RG; Bayón GF; Dmitrijeva M; Toraño EG; Bravo C; Fraga MF; Bassas L; Larriba S; Fernández AF
    Hum Reprod; 2015 May; 30(5):1014-28. PubMed ID: 25753583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.